Drugs Pharma Companies Research White Paper 
PerkinElmer
FEBRUARY 18, 2021
Industry leaders reveal how high throughput screening is changing in R&D What do you think are the major trends in drug discovery R&D? That is not what PerkinElmer found in a comprehensive survey of leaders at the top 20 Pharma, ranked for R&D spending. A PerkinElmer White Paper offers a detailed look at the findings.
H1 Blog
NOVEMBER 15, 2023
Anti-kickback laws are federal statutes designed to protect patients from paying more than necessary for medical services or devices by preventing physicians from receiving kickbacks or bribes in exchange for referring patients to certain providers or prescribing certain drugs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
SEPTEMBER 11, 2020
In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. acting, water-soluble version of remdesivir.
Drug Discovery World
SEPTEMBER 29, 2022
Challenges in outsourcing drug discovery. The goal of drug discovery is clear: Identify the most promising leads in the shortest amount of time. Many companies have several projects ongoing simultaneously, which can limit internal resources (space, lab equipment, personnel) and delay progress.
The Pharma Data
OCTOBER 16, 2020
As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. Download Medidata’s white paper to learn how to virtualize clinical trials and bring new therapies closer to patients.
Expert insights. Personalized for you.
52 
Let's personalize your content